Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic
- PMID: 34844657
- PMCID: PMC8628273
- DOI: 10.1186/s13054-021-03831-y
Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic
Conflict of interest statement
CK reports personal fees from Maquet, personal fees from Xenios, personal fees from Bayer, non-financial support from Speaker of the German register of ICUs, grants from the German Ministry of Research and Education, during the conduct of the study. TB, WW and SWC have nothing to disclose. AS reports personal fees from Baxter and Xenios in relation to consulting with respect to ECMO. DB receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios and Cellenkos.
Figures
Comment in
-
Choosing the right reference cohort for assessing outcome of venovenous ECMO.Crit Care. 2022 Jan 10;26(1):17. doi: 10.1186/s13054-021-03880-3. Crit Care. 2022. PMID: 35012622 Free PMC article. No abstract available.
References
-
- Barbaro RP MG, Boonstra PS, Combes A, Agerstrand CL, Annich G, Diaz R, Fan E, Hryniewicz K, Lorusso R, Paden ML, Stead CM, Swol J, Iwashyna TJ, Slutsky AS, Brodie D; for the Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation for COVID-19: Evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet 2021; (in press August 19). - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical